guest ::
| Home > Publications database > Dietary intake of advanced glycation endproducts and risk of hepatobiliary cancers: A multinational cohort study. > print |
| Home > Publications database > Dietary intake of advanced glycation endproducts and risk of hepatobiliary cancers: A multinational cohort study. > print |
| 001 | 168847 | ||
| 005 | 20240229133629.0 | ||
| 024 | 7 | _ | |a 10.1002/ijc.33612 |2 doi |
| 024 | 7 | _ | |a pmid:33899229 |2 pmid |
| 024 | 7 | _ | |a 0020-7136 |2 ISSN |
| 024 | 7 | _ | |a 1097-0215 |2 ISSN |
| 024 | 7 | _ | |a altmetric:104744656 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2021-01098 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Mayén, Ana-Lucia |b 0 |
| 245 | _ | _ | |a Dietary intake of advanced glycation endproducts and risk of hepatobiliary cancers: A multinational cohort study. |
| 260 | _ | _ | |a Bognor Regis |c 2021 |b Wiley-Liss |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1634305249_1830 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a 2021 Apr 25;149(4):854-864 |
| 520 | _ | _ | |a Advanced glycation endproducts (AGEs) may contribute to liver carcinogenesis because of their proinflammatory and prooxidative properties. Diet is a major source of AGEs, but there is sparse human evidence on the role of AGEs intake in liver cancer etiology. We examined the association between dietary AGEs and the risk of hepatobiliary cancers in the European Prospective Investigation into Cancer and Nutrition prospective cohort (n = 450 111). Dietary intake of three AGEs, Nε -[carboxymethyl]lysine (CML), Nε -[1-carboxyethyl]lysine (CEL) and Nδ -[5-hydro-5-methyl-4-imidazolon-2-yl]-ornithine (MG-H1), was estimated using country-specific dietary questionnaires linked to an AGEs database. Cause-specific hazard ratios (HR) and their 95% confidence intervals (CI) for associations between dietary AGEs and risk of hepatocellular carcinoma (HCC), gallbladder and biliary tract cancers were estimated using multivariable Cox proportional hazard regression. After a median follow-up time of 14.9 years, 255 cases of HCC, 100 cases of gallbladder cancer and 173 biliary tract cancers were ascertained. Higher intakes of dietary AGEs were inversely associated with the risk of HCC (per 1 SD increment, HR-CML = 0.87, 95% CI: 0.76-0.99, HR-CEL = 0.84, 95% CI: 0.74-0.96 and HR-MH-G1 = 0.84, 95% CI: 0.74-0.97). In contrast, positive associations were observed with risk of gallbladder cancer (per 1 SD, HR-CML = 1.28, 95% CI: 1.05-1.56, HR-CEL = 1.17; 95% CI: 0.96-1.40, HR-MH-G1 = 1.27, 95% CI: 1.06-1.54). No associations were observed for cancers of the intra and extrahepatic bile ducts. Our findings suggest that higher intakes of dietary AGEs are inversely associated with the risk of HCC and positively associated with the risk of gallbladder cancer. |
| 536 | _ | _ | |a 313 - Krebsrisikofaktoren und Prävention (POF4-313) |0 G:(DE-HGF)POF4-313 |c POF4-313 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de |
| 650 | _ | 7 | |a EPIC study |2 Other |
| 650 | _ | 7 | |a advanced glycation endproducts |2 Other |
| 650 | _ | 7 | |a bile duct cancers |2 Other |
| 650 | _ | 7 | |a gallbladder cancer |2 Other |
| 650 | _ | 7 | |a hepatocellular carcinoma |2 Other |
| 700 | 1 | _ | |a Aglago, Elom K |0 0000-0002-0442-3284 |b 1 |
| 700 | 1 | _ | |a Knaze, Viktoria |b 2 |
| 700 | 1 | _ | |a Cordova, Reynalda |b 3 |
| 700 | 1 | _ | |a Schalkwijk, Casper G |b 4 |
| 700 | 1 | _ | |a Wagner, Karl-Heinz |b 5 |
| 700 | 1 | _ | |a Aleksandrova, Krasimira |b 6 |
| 700 | 1 | _ | |a Fedirko, Veronika |0 0000-0002-7805-9913 |b 7 |
| 700 | 1 | _ | |a Keski-Rahkonen, Pekka |0 0000-0001-9437-3040 |b 8 |
| 700 | 1 | _ | |a Leitzmann, Michael F |b 9 |
| 700 | 1 | _ | |a Katzke, Verena |0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4 |b 10 |u dkfz |
| 700 | 1 | _ | |a Srour, Bernard |0 P:(DE-He78)0644671d309776d45e0fc705d1156cac |b 11 |u dkfz |
| 700 | 1 | _ | |a Schulze, Matthias B |b 12 |
| 700 | 1 | _ | |a Masala, Giovanna |b 13 |
| 700 | 1 | _ | |a Krogh, Vittorio |0 0000-0003-0122-8624 |b 14 |
| 700 | 1 | _ | |a Panico, Salvatore |b 15 |
| 700 | 1 | _ | |a Tumino, Rosario |b 16 |
| 700 | 1 | _ | |a Bueno-de-Mesquita, Bas |b 17 |
| 700 | 1 | _ | |a Brustad, Magritt |b 18 |
| 700 | 1 | _ | |a Agudo, Antonio |b 19 |
| 700 | 1 | _ | |a Chirlaque López, María Dolores |b 20 |
| 700 | 1 | _ | |a Amiano, Pilar |b 21 |
| 700 | 1 | _ | |a Ohlsson, Bodil |b 22 |
| 700 | 1 | _ | |a Ramne, Stina |b 23 |
| 700 | 1 | _ | |a Aune, Dagfinn |b 24 |
| 700 | 1 | _ | |a Weiderpass, Elisabete |0 0000-0003-2237-0128 |b 25 |
| 700 | 1 | _ | |a Jenab, Mazda |b 26 |
| 700 | 1 | _ | |a Freisling, Heinz |0 0000-0001-8648-4998 |b 27 |
| 773 | _ | _ | |a 10.1002/ijc.33612 |g p. ijc.33612 |0 PERI:(DE-600)1474822-8 |n 4 |p 854-864 |t International journal of cancer |v 149 |y 2021 |x 0020-7136 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:168847 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 P:(DE-He78)0644671d309776d45e0fc705d1156cac |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-313 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Krebsrisikofaktoren und Prävention |x 0 |
| 913 | 0 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-313 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Cancer risk factors and prevention |x 0 |
| 914 | 1 | _ | |y 2021 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2021-02-04 |w ger |
| 915 | _ | _ | |a DEAL Wiley |0 StatID:(DE-HGF)3001 |2 StatID |d 2021-02-04 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2021-02-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2021-02-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2021-02-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2021-02-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-02-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2021-02-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-02-04 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-02-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2021-02-04 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b INT J CANCER : 2019 |d 2021-02-04 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b INT J CANCER : 2019 |d 2021-02-04 |
| 920 | 1 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)C020-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|